by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersRonanRx, Inc. dba RonanRx

All Warning Letters

RonanRx, Inc. dba RonanRx

Warning LetterOpen

RonanRx, Inc. dba RonanRx, 1011 Old McDade Rd. Elgin, TX 78621 hello@ronanrx.com United StatesIssued Oct 30, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations2

Issue DateOct 30, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: RonanRx, Inc. dba RonanRx
Location: RonanRx, Inc. dba RonanRx, 1011 Old McDade Rd. Elgin, TX 78621 hello@ronanrx.com United States
FEI Number: N/A
Country: United States
Issue Date: October 30, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

False & Misleading Claims/Misbranded (Telehealth)

RonanRx, Inc. dba RonanRx FDA Warning Letter, October 30, 2026